热门资讯> 正文
Sanuwave Health在与专利销售相关的500万美元付款后上涨
2025-08-23 03:11
- Sanuwave (NASDAQ:SNWV) shares rose after it announced that it has received a $5M cash payment from its third-party licensee in connection with the exercise of a previously granted acquisition option.
- The payment stems from an exclusive license and option agreement originally executed on March 6, 2024, between Sanuwave and a third-party licensee.
- Under that agreement, Sanuwave granted the licensee exclusive rights to utilize a portfolio of patents focused on intravascular shockwave applications.
- In exchange for those rights and the option to acquire the patents outright, the licensee paid Sanuwave a one-time licensing fee of $2.5M.
- The stock is up 8% today.
More on SANUWAVE Health
- SANUWAVE Health, Inc. 2025 Q2 - Results - Earnings Call Presentation
- SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript
- Sanuwave: High Growth Wound Care Tech Primed For A Breakout
- SANUWAVE outlines Q3 revenue target of $12M–$12.7M as new applicator production nears launch
- Seeking Alpha’s Quant Rating on SANUWAVE Health
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。